Literature DB >> 17650288

Increased liver mast cell recruitment in patients with chronic C virus-related hepatitis and histologically documented steatosis.

B Franceschini1, C Russo, N Dioguardi, F Grizzi.   

Abstract

Hepatitis C virus (HCV) is still one of the major causes of chronic viral infection worldwide, and hepatic steatosis is a frequent pathological finding in patients with chronic HCV-related diseases. It is unclear whether the steatosis is associated with host factors or the virus itself, although a consistent relationship has been found between steatosis and a necro-inflammatory reaction with the increased secretion of immuno-regulators. A primary sources of inflammatory mediators are mast cells (MCs) bone marrow-derived cells that are detected in both normal and diseased livers. We determined MC density and correlated it with the fibrosis, inflammatory reaction and steatosis observed in the liver biopsies of patients affected by HCV with or without steatosis. All the histological features were assessed using a computer-aided image analysis system. There was a statistically significant difference in MC density between the HCV-infected patients with and without steatosis, with the lower mean value being detected in those without (P < 0.02). Furthermore, a nonstatistically significant difference in fibrosis and inflammation between the two patient groups was found. In conclusion, this is the first study showing a significant increase in MC density in the tissues of patients with chronic HCV infection and histologically documented steatosis.

Entities:  

Mesh:

Year:  2007        PMID: 17650288     DOI: 10.1111/j.1365-2893.2007.00859.x

Source DB:  PubMed          Journal:  J Viral Hepat        ISSN: 1352-0504            Impact factor:   3.728


  10 in total

Review 1.  The emerging role of mast cells in liver disease.

Authors:  Veronica Jarido; Lindsey Kennedy; Laura Hargrove; Jennifer Demieville; Joanne Thomson; Kristen Stephenson; Heather Francis
Journal:  Am J Physiol Gastrointest Liver Physiol       Date:  2017-05-04       Impact factor: 4.052

Review 2.  Angiogenesis and Hepatic Fibrosis: Western and Chinese Medicine Therapies on the Road.

Authors:  Jing-Si Wang; Qiu-Yun Zhang; Jin-Lian Cheng; Lan-Yu Chen; Nai-Li Yao; Gui-Zhi Sun; Yu-Ling Chu
Journal:  Chin J Integr Med       Date:  2018-06-25       Impact factor: 1.978

3.  Mast cell deficiency attenuates progression of atherosclerosis and hepatic steatosis in apolipoprotein E-null mice.

Authors:  Donald D Smith; Xiaoyu Tan; Vineesh V Raveendran; Ossama Tawfik; Daniel J Stechschulte; Kottarappat N Dileepan
Journal:  Am J Physiol Heart Circ Physiol       Date:  2012-04-13       Impact factor: 4.733

Review 4.  Liver fibrosis and repair: immune regulation of wound healing in a solid organ.

Authors:  Antonella Pellicoro; Prakash Ramachandran; John P Iredale; Jonathan A Fallowfield
Journal:  Nat Rev Immunol       Date:  2014-03       Impact factor: 53.106

5.  Mast Cells Promote Nonalcoholic Fatty Liver Disease Phenotypes and Microvesicular Steatosis in Mice Fed a Western Diet.

Authors:  Lindsey Kennedy; Vik Meadows; Amelia Sybenga; Jennifer Demieville; Lixian Chen; Laura Hargrove; Burcin Ekser; Wasim Dar; Ludovica Ceci; Debjyoti Kundu; Konstantina Kyritsi; Linh Pham; Tianhao Zhou; Shannon Glaser; Fanyin Meng; Gianfranco Alpini; Heather Francis
Journal:  Hepatology       Date:  2021-05-24       Impact factor: 17.298

6.  One or two ligatures inducing periodontitis are sufficient to cause fatty liver.

Authors:  L-S Pessoa; F-R Pereira-da Silva; E-H-P Alves; L-F-C França; D di Lenardo; J-S Carvalho; V-B-D Martins; F-B-M Sousa; K-O Drumond; J-V-R Medeiros; J-S de Oliveira; D-F-P Vasconcelos
Journal:  Med Oral Patol Oral Cir Bucal       Date:  2018-05-01

Review 7.  Mast Cell Responses to Viruses and Pathogen Products.

Authors:  Jean S Marshall; Liliana Portales-Cervantes; Edwin Leong
Journal:  Int J Mol Sci       Date:  2019-08-30       Impact factor: 5.923

Review 8.  Exploring the role of mast cells in the progression of liver disease.

Authors:  Shizhuan Huang; Haotian Wu; Feng Luo; Bin Zhang; Tianwei Li; Zongrui Yang; Bixuan Ren; Wenze Yin; Dehai Wu; Sheng Tai
Journal:  Front Physiol       Date:  2022-09-13       Impact factor: 4.755

Review 9.  Adverse outcome pathway development from protein alkylation to liver fibrosis.

Authors:  Tomislav Horvat; Brigitte Landesmann; Alfonso Lostia; Mathieu Vinken; Sharon Munn; Maurice Whelan
Journal:  Arch Toxicol       Date:  2016-08-19       Impact factor: 5.153

10.  Increased Mast Cell Activation in Mongolian Gerbils Infected by Hepatitis E Virus.

Authors:  Tianlong Liu; Peng Xiao; Ruiwen Li; Ruiping She; Jijing Tian; Jingyuan Wang; Jingjing Mao; Jun Yin; Ruihan Shi
Journal:  Front Microbiol       Date:  2018-10-02       Impact factor: 5.640

  10 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.